Market Place
Sourcing Support
Falk Pharma, Renexxion Announce Positive Phase 2b MOVE-IT Trial
04 May 2026 //
GLOBENEWSWIRE
DR. Falk, Renexxion to Present Phase 2B Gastroparesis Trial Data
16 Apr 2026 //
GLOBENEWSWIRE
Merck Signs Agreement with Dr. Falk Pharma GmbH for MK-8690
04 Nov 2025 //
PRESS RELEASE
Dr. Falk Pharma, Allianthera Partner for AhR Agonist Development
30 Jul 2025 //
GLOBENEWSWIRE
Renexxion, Dr. Falk Complete Ph2b Gastroparesis Trial
27 May 2025 //
GLOBENEWSWIRE
Dr. Falk Pharma reports positive phase 3 trial on norucholic acid
07 May 2025 //
GLOBENEWSWIRE
Dr. Falk Pharma Acquires Kynos, Focuses on Acute Pancreatitis
29 Oct 2024 //
ACCESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.